H.C. Wainwright analyst Amit Dayal lowered the price target on Second Sight Medical (NASDAQ: EYES) to $2.50 (from $5.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE